LONDON--()--Over the coming decade, coagulation testing practice is bound to be revolutionized owing to rising pressures for cost containment in leading industrialized countries and ongoing technology developments.
“Innovative Proteins C and S Diagnostic Testing Technologies and Emerging Markets”
New specific and sensitive hemostasis markers will be increasingly analyzed using automated equipment. Coagulation testing, and proteins C and S testing in particular, will turn out to be more standardized, thus enabling quality control products and services. The perpetual contraction of the health care system and evolving technologies will aid in bringing the proteins C and S testing nearer to patients. To that end, both established and emerging suppliers will have to face a range of additional opportunities and challenges.
New market research report “Innovative Proteins C and S Diagnostic Testing Technologies and Emerging Markets” worked out by Venture Planning Group (VPG) presents a detailed analysis of the proteins C and S testing market in the US, Europe (France, Germany, Italy, Spain, the UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forecasts by country and market segment.
The study examines market applications of chromogenic substrates, monoclonal antibodies, immunoassays, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles top suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
Report Details:
Title: Innovative Proteins C and S Diagnostic Testing Technologies and Emerging Markets
Published: November, 2012
Pages: 194
Price: US$ 3,850.00
More Diagnostic Testing Technologies & Emerging Markets Reports by VPG are Also Available:
- Innovative Factor Assays Diagnostic Testing Technologies and Emerging Markets
- Innovative PT Diagnostic Testing Technologies and Emerging Markets
- Innovative APTT Diagnostic Testing Technologies and Emerging Markets
- Innovative Heparin Diagnostic Testing Technologies and Emerging Markets
- Innovative Fibrinogen Diagnostic Testing Technologies and Emerging Markets
- Innovative Alpha-2 Antiplasmin Diagnostic Testing Technologies and Emerging Markets
- Innovative Antithrombin III Diagnostic Testing Technologies and Emerging Markets
More new market research reports by VPG can be found at http://marketpublishers.com/members/vpg/info.html





